Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 69 Myelodysplastic Syndromes 39 Leukemia 23 Leukemia, Myelomonocytic, Chronic 20 Congenital Abnormalities 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Myeloproliferative Disorders 7 Blast Crisis 6 Recurrence 5 Neoplasms 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Carcinoma, Non-Small-Cell Lung 5 Thrombocythemia, Essential 4 Primary Myelofibrosis 4 Polycythemia Vera 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lung Neoplasms 3 Leukemia, Monocytic, Acute 3 Burkitt Lymphoma 3 Anemia, Refractory, with Excess of Blasts 3 Anemia, Refractory 3 Small Cell Lung Carcinoma 2 Neuroblastoma 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Melanoma 2

Interventions

Doxorubicin 71 Ifosfamide 48 Radiotherapy 38 Filgrastim 37 Gemcitabine 32 Cyclophosphamide 31 Etoposide 24 Vincristine 23 pazopanib 20 Docetaxel 20 Cisplatin 19 Trabectedin 18 Carboplatin 15 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 12 Mesna 12 Sorafenib 11 Melphalan 11 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 eribulin 10 Sirolimus 10 Bevacizumab 10 pegfilgrastim 9 Topotecan 9 Paclitaxel 9 Temozolomide 8 Surgical Procedures, Operative 8 Dactinomycin 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02959164 2023-07-28

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

University of Iowa

Phase 1 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡